Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_assertion wasGeneratedBy ECO_0000203 NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_assertion wasDerivedFrom befree-20150227 NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_assertion SIO_000772 22351695 NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_assertion evidence source_evidence_literature NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.
- NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622563.RAe_ugv4gbKL3ed1wz8LTxfeX3xMJlYaZNCjkU_9bm4lY130_provenance.